News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,934 Results
Type
Article (87229)
Company Profile (722)
Press Release (769958)
Multimedia
Podcasts (163)
Webinars (25)
Section
Business (232971)
Career Advice (4136)
Deals (39782)
Drug Delivery (133)
Drug Development (91201)
Employer Resources (201)
FDA (18246)
Job Trends (17387)
News (397193)
Policy (39894)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (34)
Allergies (118)
Alliances (56979)
ALS (135)
Alzheimer's disease (1641)
Antibody-drug conjugate (ADC) (204)
Approvals (18235)
Artificial intelligence (452)
Autoimmune disease (48)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (46)
Breast cancer (435)
Cancer (3522)
Cardiovascular disease (306)
Career advice (3550)
Career pathing (36)
CAR-T (229)
CDC (46)
Cell therapy (626)
Cervical cancer (29)
Clinical research (74904)
Collaboration (1274)
Company closure (4)
Compensation (857)
Complete response letters (50)
COVID-19 (2939)
CRISPR (77)
C-suite (498)
Cystic fibrosis (129)
Data (3723)
Decentralized trials (2)
Denatured (58)
Depression (96)
Diabetes (412)
Diagnostics (7042)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (214)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (181)
Earnings (98632)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132384)
Executive appointments (954)
FDA (20456)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1126)
Gene editing (164)
Generative AI (44)
Gene therapy (493)
GLP-1 (987)
Government (5345)
Grass and pollen (7)
Guidances (332)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (221)
Immuno-oncology (17)
Indications (46)
Infectious disease (3156)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (158)
Interviews (814)
IPO (17921)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (624)
Leadership (30)
Legal (10144)
Liver cancer (89)
Longevity (12)
Lung cancer (511)
Lymphoma (251)
Machine learning (22)
Management (65)
Manufacturing (554)
MASH (117)
Medical device (14824)
Medtech (14842)
Mergers & acquisitions (22673)
Metabolic disorders (1059)
Multiple sclerosis (116)
NASH (23)
Neurodegenerative disease (181)
Neuropsychiatric disorders (49)
Neuroscience (2527)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (534)
Opinion (302)
Ovarian cancer (114)
Pain (152)
Pancreatic cancer (145)
Parkinson's disease (213)
Partnered (27)
Patents (380)
Patient recruitment (264)
Peanut (56)
People (66046)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23094)
Phase II (32525)
Phase III (24479)
Pipeline (2433)
Policy (277)
Postmarket research (3554)
Preclinical (10427)
Press Release (72)
Prostate cancer (171)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (595)
Real estate (7411)
Recruiting (76)
Regulatory (27664)
Reports (64)
Research institute (2674)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (117)
Series A (183)
Series B (139)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (92)
Tariffs (82)
The Weekly (103)
Vaccines (1006)
Venture capital (63)
Weight loss (366)
Women's health (56)
Worklife (21)
Date
Today (64)
Last 7 days (493)
Last 30 days (2303)
Last 365 days (33938)
2025 (23473)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (293)
Arkansas (14)
Asia (50784)
Australia (8920)
California (8871)
Canada (2691)
China (833)
Colorado (375)
Connecticut (393)
Delaware (239)
Europe (116627)
Florida (1307)
Georgia (302)
Hawaii (3)
Idaho (67)
Illinois (785)
India (45)
Indiana (427)
Iowa (19)
Japan (267)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1212)
Massachusetts (6687)
Michigan (295)
Minnesota (540)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (101)
New Hampshire (76)
New Jersey (2446)
New Mexico (31)
New York (2416)
North Carolina (1353)
North Dakota (10)
Northern California (3942)
Ohio (279)
Oklahoma (18)
Oregon (49)
Pennsylvania (1852)
Puerto Rico (18)
Rhode Island (44)
South America (1654)
South Carolina (45)
South Dakota (1)
Southern California (3368)
Tennessee (142)
Texas (1385)
United States (32924)
Utah (265)
Virginia (238)
Washington D.C. (82)
Washington State (760)
West Virginia (4)
Wisconsin (91)
There are 857,934 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alprostadil Injection Market Size to worth USD 347.8 Million by 2032, says Coherent Market Insights
September 15, 2025
·
1 min read
Press Releases
Vaccines Market Poised for Growth, Expected to Hit USD 124.88 Billion by 2032, says Coherent Market Insights
September 15, 2025
·
1 min read
Collaboration
Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B
Novartis and Monte Rosa first partnered in October 2024 for a molecular glue asset for immune-mediated and autoimmune diseases. This time, the pharma is putting $120 million down upfront for more of the biotech’s AI-discovered degraders.
September 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab
September 15, 2025
·
13 min read
Press Releases
Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates
September 15, 2025
·
11 min read
Press Releases
Spruce Biosciences Resumes Trading on the Nasdaq Capital Market
September 15, 2025
·
1 min read
Press Releases
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
September 15, 2025
·
8 min read
Press Releases
CatalYm Announces Leadership Changes to Accelerate Visugromab Late-stage Clinical Development
September 15, 2025
·
4 min read
Press Releases
New data for Kodiak’s KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
September 15, 2025
·
11 min read
Press Releases
Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial of QTORIN™ Rapamycin for Cutaneous Venous Malformations
September 15, 2025
·
7 min read
1 of 85,794
Next
